Pozelimab
R3918-PNH-2483
Phase 3 small_molecule active
Quick answer
Pozelimab for Paroxysmal Nocturnal Hemoglobinuria is a Phase 3 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 4 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Paroxysmal Nocturnal Hemoglobinuria
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active